Enhancing site-specific DNA integration by a Cas9 nuclease fused with a DNA donor-binding domain

Shufeng Ma,Xinlong Wang,Yongfei Hu,Jie Lv,Chengfang Liu,Kaitong Liao,Xiaohua Guo,Dong Wang,Ying Lin,Zhili Rong
DOI: https://doi.org/10.1093/nar/gkaa779
IF: 14.9
2020-09-28
Nucleic Acids Research
Abstract:Abstract The CRISPR/Cas system is widely used for genome editing. However, robust and targeted insertion of a DNA segment remains a challenge. Here, we present a fusion nuclease (Cas9-N57) to enhance site-specific DNA integration via a fused DNA binding domain of Sleeping Beauty transposase to tether the DNA segment to the Cas9/sgRNA complex. The insertion was unidirectional and specific, and DNA fragments up to 12 kb in length were successfully integrated. As a test of the system, Cas9-N57 mediated the insertion of a CD19-specific chimeric antigen receptor (CD19-CAR) cassette into the AAVS1 locus in human T cells, and induced intrahepatic cholangiocarcinoma in mice by simultaneously mediating the insertion of oncogenic KrasG12D into the Rosa26 locus and disrupting Trp53 and Pten. Moreover, the nuclease-N57 fusion proteins based on AsCpf1 (AsCas12a) and CjCas9 exhibited similar activity. These findings demonstrate that CRISPR-associated nuclease-N57 protein fusion is a powerful tool for targeted DNA insertion and holds great potential for gene therapy applications.
biochemistry & molecular biology
What problem does this paper attempt to address?